A detailed history of Axq Capital, LP transactions in Viatris Inc stock. As of the latest transaction made, Axq Capital, LP holds 37,256 shares of VTRS stock, worth $399,384. This represents 0.14% of its overall portfolio holdings.

Number of Shares
37,256
Holding current value
$399,384
% of portfolio
0.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$8.74 - $10.69 $325,617 - $398,266
37,256 New
37,256 $369 Million
Q2 2024

Aug 13, 2024

SELL
$10.05 - $12.02 $112,861 - $134,984
-11,230 Reduced 42.06%
15,470 $164 Million
Q1 2024

May 14, 2024

BUY
$11.27 - $13.53 $300,909 - $361,251
26,700 New
26,700 $319 Million
Q1 2023

May 10, 2023

BUY
$9.2 - $12.26 $155,047 - $206,617
16,853 New
16,853 $162 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Axq Capital, LP Portfolio

Follow Axq Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axq Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Axq Capital, LP with notifications on news.